Antibiotic-resistant typhoid accounts for 87% of India’s economic burden, costing ₹123 billion in 2023, with children under 10 most affected. https://english.mathrubhumi.com/lifestyle/health/economic-burden-antibiotic-resistant-typhoid-india-k8n3d3qn?utm_source=dlvr.it&utm_medium=mastodon #Typhoid #AntibioticResistance #PublicHealthIndia #Vaccination #India